Your browser doesn't support javascript.
loading
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Kapp-Schwoerer, Silke; Weber, Daniela; Corbacioglu, Andrea; Gaidzik, Verena I; Paschka, Peter; Krönke, Jan; Theis, Frauke; Rücker, Frank G; Teleanu, Maria-Veronica; Panina, Ekaterina; Jahn, Nikolaus; Herzig, Julia; Kubanek, Lena; Schrade, Anika; Göhring, Gudrun; Fiedler, Walter; Kindler, Thomas; Schroeder, Thomas; Mayer, Karin T; Lübbert, Michael; Wattad, Mohammed; Götze, Katharina S; Horst, Heinz A; Koller, Elisabeth; Wulf, Gerald; Schleicher, Jan; Bentz, Martin; Krauter, Jürgen; Bullinger, Lars; Krzykalla, Julia; Benner, Axel; Schlenk, Richard F; Thol, Felicitas; Heuser, Michael; Ganser, Arnold; Döhner, Hartmut; Döhner, Konstanze.
Afiliación
  • Kapp-Schwoerer S; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Weber D; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Corbacioglu A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Gaidzik VI; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Paschka P; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Krönke J; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Theis F; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Rücker FG; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Teleanu MV; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Panina E; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Jahn N; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Herzig J; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Kubanek L; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Schrade A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Göhring G; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Fiedler W; Hubertus Wald University Cancer Center, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Kindler T; Department of Hematology, Medical Oncology, and Pneumology, University Cancer Center Mainz, Mainz, Germany.
  • Schroeder T; Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Mayer KT; Department of Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
  • Lübbert M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Wattad M; Department of Hematology, Oncology and Stem Cell Transplantation, Kliniken Essen Süd, Essen, Germany.
  • Götze KS; III. Department of Medicine, Hematology, and Medical Oncology, Technical University of Munich, Munich, Germany.
  • Horst HA; Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.
  • Koller E; III. Department of Medicine, Hematology, and Medical Oncology, Hanuschkrankenhaus Wien, Vienna, Austria.
  • Wulf G; Department of Hematology and Oncology, Georg-August-University Göttingen, Göttingen, Germany.
  • Schleicher J; Department of Hematology and Oncology, Katharinenhospital Stuttgart, Stuttgart, Germany.
  • Bentz M; Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany.
  • Krauter J; Department of Internal Medicine III, Municipal Hospital of Braunschweig, Braunschweig, Germany.
  • Bullinger L; Department of Hematology, Oncology, and Tumorimmunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
  • Krzykalla J; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Benner A; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Schlenk RF; Nationales Centrum für Tumorerkrankungen Trial Center, National Center of Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Thol F; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; and.
  • Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Döhner H; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Blood ; 136(26): 3041-3050, 2020 12 24.
Article en En | MEDLINE | ID: mdl-33367545
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_leukemia Asunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda / Gemtuzumab / Mutación / Proteínas de Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_leukemia Asunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda / Gemtuzumab / Mutación / Proteínas de Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article País de afiliación: Alemania